Why These 5 Stocks Are Trending on Monday
5. Caterpillar Inc. (NYSE:CAT) shares have surged 4% after Mircea Dobre of Baird made the stock a 'fresh pick' and reiterated an 'outperform' rating. Dobre has a $290 price target as Caterpillar Inc.
Regeneron Pharmaceuticals Inc. (REGN)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Harris Associates Natixis Global Asset Management | 1,326,296 | $802,648 | -9% | 1.27% |
| 2. | ARK Investment Management Catherine D. Wood | 428,147 | $259,106 | -40% | 0.62% |
| 3. | 392,800 | $237,715 | +17% | 0.04% | |
| 4. | 301,000 | $182,159 | +7% | 0.03% | |
| 5. | 286,600 | $173,445 | +123% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $487.01 | 2,557 | 23,880,537 | 2017-08-25 | Filing | ||
| $485.99 | 2,681 | 23,877,980 | 2017-08-25 | Filing | ||
| $485.28 | 5,723 | 23,875,299 | 2017-08-25 | Filing | ||
| $484.21 | 2,000 | 23,869,576 | 2017-08-25 | Filing | ||
| $482.87 | 4,485 | 23,867,576 | 2017-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $641.23 | 6 | Director | 22,491 | 2021-12-01 | Filing | |
| $640.47 | 5 | Director | 22,497 | 2021-12-01 | Filing | |
| $639.49 | 24 | Director | 22,502 | 2021-12-01 | Filing | |
| $638.62 | 12 | Director | 22,526 | 2021-12-01 | Filing | |
| $637.75 | 22 | Director | 22,538 | 2021-12-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 524,211 | $317,242,012 | 0.13% | |
| 2. | 49,267 | $29,815,403 | 0.04% | |
| 3. | 432 | $26,143,776 | 0.03% | |
| 4. | 40,248 | $24,357,285 | 0.15% | |
| 5. | 23,060 | $13,955,450 | 0.16% |
News See All
Was The Smart Money Right About Regeneron Pharmaceuticals Inc (REGN)?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
10 Best COVID Stocks To Buy Now
Covid-19 crushed almost every sector, resulting in the world economy shrinking by 3.2% in 2020.
10 Best Cancer Stocks To Buy Now
In this article, we discuss the 10 best cancer stocks to buy now.
10 Healthcare Stocks to Buy According to Billionaire Noam Gottesman’s GLG Partners
In this article, we will be taking a look at the 10 healthcare stocks to buy according to billionaire Noam Gottesman's GLG Partners.
Hedge Funds Are Coming Back To Regeneron Pharmaceuticals Inc (REGN)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Why These 5 Stocks Are on the Move on Friday
5. Expedia Group, Inc. (NASDAQ:EXPE) has surged 3.5% due to today's rally in many travel related stocks as a result of the Merck antiviral news.
10 Best Healthcare Stocks to Buy According to Matthew Halbower’s Pentwater Capital Management
In this article, we discuss the 10 best healthcare stocks to buy according to Matthew Halbower's Pentwater Capital Management.
Is Regeneron Pharmaceuticals (REGN) A Worthy Investment?
Oakmark Funds, an investment management firm, published its “Oakmark Select Fund” second quarter 2021 investor letter – a copy of which can be seen here. A return of 7.96% was reported by the ...
Bronte Capital on Regeneron (REGN): “A Winner in Mouse Genetics”
Bronte Capital, an investment management firm, published its “Amalthea Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Billionaire Hedge Funds
